Tianda Pharmaceuticals Ltd
HKEX:455
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tianda Pharmaceuticals Ltd
HKEX:455
|
HK |
|
W
|
Wot Co Ltd
KOSDAQ:396470
|
KR |
|
A
|
Asahi Kasei Corp
DUS:ASAA
|
JP |
|
H
|
Heidelberg Materials AG
SWB:HEI
|
DE |
|
Bayan Resources Tbk PT
F:BNB
|
ID |
|
Rolls-Royce Holdings PLC
OTC:RYCEF
|
UK |
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
MY |
|
U
|
Ubiquiti Inc
F:3UB
|
US |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
Adagene Inc
NASDAQ:ADAG
|
CN |
Dividends
Dividend Yield
Tianda Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Tianda Pharmaceuticals Ltd
Payout Ratio
Tianda Pharmaceuticals Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Tianda Pharmaceuticals Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Tianda Pharmaceuticals Ltd
| Average Annual Return | -14.02% |
| Standard Deviation of Annual Returns | 28.42% |
| Max Drawdown | -80% |
| Market Capitalization | 253.7m HKD |
| Shares Outstanding | 2 150 040 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Tianda Pharmaceuticals Ltd's latest stock split occurred on Jul 8, 2010
The company executed a 55-for-38 stock split, meaning that for every 38 shares held, investors received 55 new shares.
The adjusted shares began trading on Jul 8, 2010. This was stock split number 3 in Tianda Pharmaceuticals Ltd's history, following the previous one in Sep 2, 1999.